Dr. Tamminga is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2201 Inwood Road
NC6.102
Dallas, TX 75209Phone+1 214-648-1108
Education & Training
- University of ChicagoResidency, Psychiatry, 1972 - 1975
- Grand Rapids Medical Education and Research Center/ Michigan State University (East Campus)Internship, Transitional Year, 1971 - 1972
- Vanderbilt University School of MedicineClass of 1971
- Calvin College Health CenterB.S., Biochemistry, 1963 - 1966
Certifications & Licensure
- TX State Medical License 2003 - 2027
- TX State Medical License 2003 - 2026
- MD State Medical License 1981 - 2015
- IL State Medical License 1972 - 1987
Awards, Honors, & Recognition
- Gold Award society of Biological Psychiatry, 2019
- Program Chair Award Society for Neuroscience, 2013
- Founders Award International Congress on Schizophrenia Research, 2012
- Join now to see all
Clinical Trials
- Treating Cognition in Schizophrenia With Atomoxetine and Cognitive Remediation Start of enrollment: 2003 Sep 01
- Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia Start of enrollment: 2007 Nov 01
- Study to Demonstrate Cognitive Enhancing Effects of BF2.649 Start of enrollment: 2008 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 614 citationsAltered Gene Expression of Brain-Derived Neurotrophic Factor and Receptor Tyrosine Kinase B in Postmortem Brain of Suicide SubjectsYogesh Dwivedi, Hooriyah S. Rizavi, Robert R. Conley, Rosalinda C. Roberts, Carol A. Tamminga
Archives of General Psychiatry. 2003-08-01 - 268 citationsIonotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia.Xue Min Gao, Kazuo Sakai, Rosalinda C. Roberts, Robert R. Conley, Brian Dean
The American Journal of Psychiatry. 2000-07-01 - 1645 citationsMolecular Adaptations Underlying Susceptibility and Resistance to Social Defeat in Brain Reward RegionsVaishnav Krishnan, Ming-Hu Han, Danielle Graham, Olivier Berton, William Renthal
Cell. 2007-10-19
Journal Articles
- Using Brain-Based Phenotyping to Improve Discovery in PsychiatryCarol A Tamminga, Elena I Ivleva, JAMA
- New Approaches in Psychiatric Drug DevelopmentWayne C Drevets, Carol A Tamminga, European Neuropsychopharmacology
- Animal models of schizophrenia emphasizing constructvalidityYanagi M, Southcott S, Lister J, Tamminga CA, Prog Mol Biol Transl Sci, 1/1/2012
- Join now to see all
Authored Content
- New Approaches in Psychiatric Drug DevelopmentJuly 2018
- S188. Emotional Processing in Bipolar Disorder with and Without Psychosis: Findings from the Psychosis and Affective Research Domains and Intermediate Phenotypes ConsortiumApril 2018
- S188. Emotional Processing in Bipolar Disorder with and Without Psychosis: Findings from the Psychosis and Affective Research Domains and Intermediate Phenotypes ConsortiumApril 2018
- WelcomeMarch 2018
- WelcomeMarch 2018
- Join now to see all
Press Mentions
- DFW’s State Hospital Will Be by and for the PeopleJanuary 11th, 2022
- NS/ Brain Study on How to Slow down Climate ChangeDecember 22nd, 2021
- First Human Evidence of How Memories Form: StudyDecember 14th, 2021
- Join now to see all
Grant Support
- Antipsychotic Influence On Altered MTL Neuronal Activity In SchizophreniaNational Institute Of Mental Health2009–2012
- Project 5-Creb And The Other Targets In Projects 1-4 In Reward Regions In DepressNational Institute Of Mental Health2010–2011
- Basic Science Training Program In The Neurobiology Of Mental IllnessNational Institute Of Mental Health2007–2011
- Bipolar &Schizophrenia Consortium For Parsing Intermediate PhenotypesNational Institute Of Mental Health2007–2010
- Project 5-Creb And The Other Targets In Projects 1-4 In Reward Regions In DepressNational Institute Of Mental Health2008–2009
- Treating Cognition In SchizophreniaNational Institute Of Mental Health2007–2009
- Project 5-Creb And The Other Targets In Projects 1-4 In Reward Regions In DepressNational Institute Of Mental Health2007
- Comparitive Antipsychotic Drug Actions On Brain NeurochemistryNational Institute Of Mental Health2007
- Psychiatric Research Education Program(Prep)National Institute Of Mental Health2006–2007
- Comparitive Antipsychotic Drug Actions On Brain NeurocheNational Institute Of Mental Health2004–2006
- Examination Of The Limbic Cortex In SchizophreniaNational Institute Of Mental Health2003–2006
- Antipsychotic Drug Actions On Brain NeurochemistryNational Institute Of Mental Health2003
- Examination Of The Limbic Cortex In SchizophreniaNational Institute Of Mental Health2002
- Partial Dopamineagonist Treatment Of SchizophreniaNational Institute Of Mental Health2001–2002
- Clinical Biology CoreNational Institute Of Mental Health1998–2002
- Partial Dopamine Agonist Treatment Of SchizophreniaNational Institute Of Mental Health2000
- GABA Agonist Therapy In Tardive DyskinesiaNational Institute Of Mental Health1985–1999
- Clinical Biochemistry Laboratory CoreNational Institute Of Mental Health1996–1997
- Partial Dopamine Agonists--Treatment Of SchizophreniaNational Institute Of Mental Health1995–1997
- Partial Dopamine Agonists In Treatment Of SchizophreniaNational Institute Of Mental Health1992–1994
- GABA Agonist Therapy In Tardive DyskinesiaNational Institute Of Mental Health1987–1994
- Regional Brain Glucose UtilizationNational Institute Of Mental Health1987–1989
- Haloperidol Kinetics In Persistent PsychosisNational Institute Of Mental Health1986–1988
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: